Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

J.G. Gaultney, M.G. Franken, S.S. Tan, W.K. Redekop, P.C. Huijgens, P. Sonneveld, C.A. Uyl-de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)41-47
JournalJournal of Clinical Pharmacy and Therapeutics
Issue number1
Publication statusPublished - 2013

Cite this